Total Payments
$3,433
2024 Payments
$271.60
Companies
16
Transactions
52
Medicare Patients
7,778
Medicare Billing
$6.4M
Payment Breakdown by Category
Consulting$1,575 (45.9%)
Food & Beverage$1,267 (36.9%)
Other$590.79 (17.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,575 | 1 | 45.9% |
| Food and Beverage | $1,267 | 50 | 36.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $590.79 | 1 | 17.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cardinal Health 108 LLC | $1,575 | 1 | $0 (2020) |
| Notal Vision, Inc. | $590.79 | 1 | $0 (2022) |
| Topcon Healthcare, Inc. | $171.64 | 1 | $0 (2024) |
| Allergan, Inc. | $167.82 | 10 | $0 (2021) |
| Genentech USA, Inc. | $165.19 | 8 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $161.91 | 2 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $135.74 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $95.46 | 6 | $0 (2021) |
| Mallinckrodt LLC | $78.14 | 4 | $0 (2018) |
| ABBVIE INC. | $70.49 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $271.60 | 5 | Topcon Healthcare, Inc. ($171.64) |
| 2023 | $75.13 | 3 | Astellas Pharma US Inc ($30.93) |
| 2022 | $659.20 | 4 | Notal Vision, Inc. ($590.79) |
| 2021 | $190.59 | 9 | Allergan, Inc. ($43.75) |
| 2020 | $1,715 | 10 | Cardinal Health 108 LLC ($1,575) |
| 2019 | $141.47 | 6 | Bausch & Lomb, a division of Bausch Health US, LLC ($37.83) |
| 2018 | $300.21 | 11 | Regeneron Healthcare Solutions, Inc. ($122.57) |
| 2017 | $79.58 | 4 | Valeant Pharmaceuticals North America LLC ($37.14) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $171.64 | General |
| 10/15/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: EYE CARE | ||||||
| 10/08/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: EYE CARE | ||||||
| 01/17/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Ophthalmology | ||||||
| 09/05/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $30.93 | General |
| 09/05/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Ophthalmology | ||||||
| 01/05/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: EYE CARE | ||||||
| 12/06/2022 | Genentech USA, Inc. | Lucentis (Biological), VABYSMO | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Ophthalmology | ||||||
| 09/14/2022 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $590.79 | General |
| 08/16/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $23.57 | General |
| 07/18/2022 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 10/14/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/15/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Ophthalmology | ||||||
| 09/15/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Ophthalmology | ||||||
| 08/17/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/03/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VISUDYNE (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Ophthalmology | ||||||
| 05/25/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/27/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: RETINA | ||||||
| 03/03/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: RETINA | ||||||
| 02/03/2021 | EyePoint Pharmaceuticals US, Inc. | DEXYCU (Drug) | Food and Beverage | In-kind items and services | $37.03 | General |
| Category: Postoperative Inflammation | ||||||
| 11/12/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: RETINA | ||||||
| 11/12/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: RETINA | ||||||
| 10/28/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VISUDYNE (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/13/2020 | Cardinal Health 108 LLC | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,915 | 36,600 | $3.3M | $1.4M |
| 2022 | 15 | 1,995 | 14,775 | $3.7M | $1.6M |
| 2021 | 14 | 1,979 | 6,671 | $3.6M | $1.6M |
| 2020 | 12 | 1,889 | 7,382 | $4.0M | $1.8M |
Total Patients
7,778
Total Services
65,428
Medicare Billing
$6.4M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 78 | 32,460 | $1.9M | $944,606 | 48.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 41 | 326 | $407,500 | $225,183 | 55.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 130 | 802 | $441,100 | $67,525 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 382 | 462 | $91,520 | $43,047 | 47.0% |
| 92134 | Imaging of retina | Office | 2023 | 480 | 1,304 | $130,400 | $38,899 | 29.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 13 | 203 | $154,570 | $30,634 | 19.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 457 | 652 | $52,940 | $12,109 | 22.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 68 | 78 | $15,600 | $8,399 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 118 | $14,375 | $7,561 | 52.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $14,525 | $7,440 | 51.2% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 38 | 42 | $8,400 | $4,272 | 50.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 30 | 31 | $6,200 | $2,912 | 47.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 12 | 15 | $1,875 | $1,103 | 58.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 25 | 27 | $4,975 | $1,006 | 20.2% |
| 92250 | Photography of the retina | Office | 2023 | 13 | 15 | $1,500 | $427.68 | 28.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 96 | 912 | $1.1M | $659,230 | 57.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 69 | 8,940 | $536,400 | $266,782 | 49.7% |
| J3490 | Unclassified drugs | Office | 2022 | 61 | 186 | $584,000 | $256,801 | 44.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 26 | 755 | $568,745 | $165,396 | 29.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 131 | 972 | $534,600 | $81,814 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 404 | 509 | $81,440 | $46,739 | 57.4% |
| 92134 | Imaging of retina | Office | 2022 | 480 | 1,473 | $147,300 | $44,059 | 29.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 461 | 668 | $66,800 | $12,234 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 151 | $15,100 | $10,042 | 66.5% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2022 | 44 | 51 | $10,200 | $5,228 | 51.3% |
About Dr. John Wroblewski, MD
Dr. John Wroblewski, MD is a Ophthalmology healthcare provider based in Hagerstown, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477521334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wroblewski, MD has received a total of $3,433 in payments from pharmaceutical and medical device companies, with $271.60 received in 2024. These payments were reported across 52 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($1,575).
As a Medicare-enrolled provider, Wroblewski has provided services to 7,778 Medicare beneficiaries, totaling 65,428 services with total Medicare billing of $6.4M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Hagerstown, MD
- Active Since 03/08/2006
- Last Updated 11/06/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1477521334
Products in Payments
- OZURDEX (Drug) $238.31
- Lucentis (Biological) $141.62
- EYLEA AFLIBERCEPT INJECTION (Biological) $122.57
- ACTHAR (Biological) $103.38
- MACUGEN (Drug) $94.64
- VISUDYNE (Drug) $78.24
- BEOVU (Drug) $65.18
- EYLEA HD (Biological) $39.34
- DEXYCU (Drug) $37.03
- XIPERE (Drug) $34.33
- Jetrea (Drug) $33.71
- YUTIQ (Drug) $22.13
- TRAVATAN Z (Drug) $12.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Hagerstown
Dr. Robert Parnes, Md, MD
Ophthalmology — Payments: $233,725
Ophthalmology $233,725
David Warrow, M.d, M.D
Ophthalmology — Payments: $79,434
Ophthalmology $79,434
Dr. Augustus Stern, M.d, M.D
Ophthalmology — Payments: $7,520
Ophthalmology $7,520
Kinga Huzella, M.d, M.D
Ophthalmology — Payments: $5,779
Ophthalmology $5,779
Dr. Adam Wenick, Md, Phd, MD, PHD
Ophthalmology — Payments: $5,101
Ophthalmology $5,101
Mr. Erwin Puente, Md, MD
Ophthalmology — Payments: $2,704
Ophthalmology $2,704